跳至主要内容
临床试验/NCT02397993
NCT02397993Unknown不适用

Serum Lipase, Amylase and CA 19-9 Prior and After EUS-guided Fine Needle Aspiration of the Pancreas

Helios Albert-Schweitzer-Klinik Northeim3 个研究点 分布在 1 个国家目标入组 208 人开始时间: 2015年3月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
208
试验地点
3
主要终点
Serum lipase

研究概览

简要总结

Endoscopic ultrasonography (EUS ) -guided fine needle aspiration (EUS -FNA ) of focal pancreatic lesions is an essential diagnostic procedure with high therapeutic effect in clinical routine.

The aim of this study is to determine the levels of serum lipase, serum amylase and the tumor marker CA 19-9 prior and after EUS-FNA. In animal experiments on dogs, an increase of all three parameters was observed after surgery on the pancreas. For humans, these clinically important data are not yet available .

It is assumed that the probability of pancreatitis with increased activity of lipase and amylase will rise with the number of puncture procedures as well as the size of the puncture needle. In addition, the post-interventional assessment of the tumor marker CA 19-9 could result in a false positive assumption of malignant neoplastic pancreatic lesion.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • independent indication for pancreatic EUS-FNA
  • age ≥ 18 years
  • patient able to give informed consent

排除标准

  • Contraindications for EUS-FNA
  • pregnancy
  • no informed consent available
  • known stenosis of esophagus or duodenum
  • relevant coagulation disorders

结局指标

主要结局

Serum lipase

时间窗: up to 24h prior to EUS-FNA and 4 hours after EUS-FNA

次要结局

  • CA 19-9(4 hours after EUS-FNA)
  • Serum amylase(4 hours after EUS-FNA)

研究者

发起方
Helios Albert-Schweitzer-Klinik Northeim
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验